Royal Bank of Canada’s BioCardia BCDA Stock Holding History

Royal Bank of Canada’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-26	Closed	–	–	6847
2024 Q2	$0	Buy	26 +18	+225%	+$90	﹤0.01%	7043
2024 Q1	$0	Sell	8 -7	-47%	-$50	﹤0.01%	7009
2023 Q4	$0	Buy	+15	New	+$122	﹤0.01%	7104

Other funds holding BCDA

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Pingora Partners Wilson, Wyoming $169M AUM 56.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GRP

Global Retirement Partners San Rafael, California $5.64B AUM

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada's BCDA Position: Q3 2024 in Review

Royal Bank of Canada sold out of BioCardia (BCDA) in Q3 2024, closing a stake of 26 shares.

Royal Bank of Canada first reported a position in BCDA in Q4 2023 and held it in 3 quarters. The position peaked at $0 in Q2 2024. 9 funds tracked by Wall St. Rank hold BCDA as of Q3 2024.

Royal Bank of Canada reported no remaining BioCardia position as of Q3 2024 after selling out during the quarter.
Royal Bank of Canada sold 26 BioCardia shares in Q3 2024.
Royal Bank of Canada first reported a position in BioCardia in Q4 2023 and held it in 3 quarters.
Royal Bank of Canada's BioCardia position peaked at $0 in Q2 2024.
9 funds tracked by Wall St. Rank held BioCardia as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.